Mavacamten May Improve LV Hypertrophy in Obstructive Hypertrophic Cardiomyopathy
Mavacamten was found to improve left ventricular hypertrophy in patients with obstructive hypertrophic cardiomyopathy.
All articles by Colby Stong
Food Insecurity May Be Associated With Increased Cardiovascular Mortality Rates
Increases in food insecurity were found to be independently associated with increased cardiovascular mortality rates in nonelderly adults.
Healthy Lifestyle Associated With Lower All-Cause Mortality Regardless of Polypharmacy
A healthy lifestyle was found to be inversely associated with all-cause mortality, regardless of polypharmacy.
Cardiovascular Risk Among Transgender Persons Initiating Gender-Affirming Hormone Therapy
Transgender persons who present for gender-affirming hormone therapy may be at an elevated cardiovascular risk.
Atrial Fibrillation Risk May Be Lowered, Delayed in African American Men With Higher Fitness Levels
Higher fitness levels were found to lower and delay the risk for atrial fibrillation among African American male veterans.
Pro-Inflammatory Diets May Increase Risk for Crohn Disease
An analysis of 3 large prospective cohorts examined the association between dietary patterns with high inflammatory potential and increased risks for Crohn disease and ulcerative colitis.
Workplace Exposure to Toxic Substances Found to Be Associated With Abnormal Cardiac Structure and Function
Occupational exposures may be associated with abnormal echocardiographic measures of cardiac function and structure.
Self-Measured Blood Pressure Monitoring: An AHA/AMA Policy Statement
Self-measured BP monitoring at home may be a cost-effective way to improve the diagnosis and management of patients with hypertension.
![The most frequent cardiovascular manifestations of AS are aortic insufficiency and conduction disorders.[2] Up to 20% of patients with AS have conduction disorders, of which atrioventricular block is the most common.[5,6] Compared with the general population, patients with AS have a 30% to 50% increase in the risk of acute coronary syndromes, deep venous thromboembolism, pulmonary embolism, or stroke.[8] They also have a 25% to 60% greater risk of ischemic heart disease, congestive heart failure, and valvular heart disease.[9] Heart failure may occur secondary to mitral insufficiency.[2] Aortic dissection, which is a rare but frequently fatal complication of aortic insufficiency, has also been observed in patients with AS.[2] Other potential cardiovascular complications include left ventricular diastolic dysfunction, pericarditis, myocardial disease, peripheral vascular disease, and hypertension.[2,3,5]](https://www.clinicaladvisor.com/wp-content/uploads/sites/11/2020/08/thinkstockphotos474641458101_1032729-544x306.jpg)
Prasugrel Dose Adapted to Age, Weight Found Efficacious for Acute Coronary Syndrome
A reduced dose of prasugrel compared with the standard dose of ticagrelor was associated with maintained anti-ischemic efficacy and safety in elderly or low-weight patients with acute coronary syndrome.
Reports of Facial Dermatosis Associated With Prolonged Face Mask Use During COVID-19
The use of PPE in the general population during the COVID-19 pandemic may be associated with the occurrence of facial dermatosis.
- Loading...
Loading...
Next post in Dermatology Information Center
Loading... 
Loading...